FDA Import Refusal 799-3917345-6/11/1 — Boehringer Ingelheim Canada
The FDA refused shipment 799-3917345-6/11/1 from Boehringer Ingelheim Canada (Canada) on Apr 11, 2023. The refused product falls under Drugs and Biologics — DUPILUMAB. Cited charges: 118,3280,75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Apr 11, 2023
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 58ACL02 DUPILUMAB
- Charges
- 118,3280,75